casirivimab/imdevimab
0 sources
casirivimab/imdevimab
Summary
casirivimab/imdevimab is an experimental drug[1]. casirivimab/imdevimab ranks in the top 10% of experimental_drug entities by monthly Wikipedia readership (43 views/month).[2]
Key Facts
- casirivimab/imdevimab's image is recorded as REGN-COV2 binding SARS-CoV-2 spike protein.png[3].
- casirivimab/imdevimab's instance of is recorded as experimental drug[4].
- casirivimab/imdevimab's instance of is recorded as combination drug[5].
- casirivimab/imdevimab's developer is recorded as Regeneron Pharmaceuticals[6].
- casirivimab/imdevimab's Commons category is recorded as Casirivimab/imdevimab[7].
- casirivimab/imdevimab's has part is recorded as casirivimab[8].
- casirivimab/imdevimab's has part is recorded as imdevimab[9].
- +2020-00-00T00:00:00Z marks the founding of casirivimab/imdevimab[10].
- casirivimab/imdevimab's DrugBank ID is recorded as DB15691[11].
- casirivimab/imdevimab's medical condition treated is recorded as COVID-19[12].
- casirivimab/imdevimab's name is recorded as {'lang': 'en', 'text': 'REGN-COV2'}[13].
- casirivimab/imdevimab's Google Knowledge Graph ID is recorded as /g/11kdlx2p0b[14].
- casirivimab/imdevimab's subject has role is recorded as antiviral drug[15].
- casirivimab/imdevimab's UK Parliament thesaurus ID is recorded as 491691[16].
- casirivimab/imdevimab's MedlinePlus drug identifier is recorded as a620063[17].
- casirivimab/imdevimab's WikiProjectMed ID is recorded as Casirivimab/imdevimab[18].
Why It Matters
casirivimab/imdevimab ranks in the top 10% of experimental_drug entities by monthly Wikipedia readership (43 views/month).[2] casirivimab/imdevimab has Wikipedia articles in 16 language editions, a strong signal of global cultural recognition.[19] casirivimab/imdevimab is known by 14 alternative names across languages and contexts.[20]